167 related articles for article (PubMed ID: 6846084)
1. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.
Puchstein C; van Aken H; Hidding J; Anger C; Lawin P
Acta Neurochir (Wien); 1983; 67(3-4):283-90. PubMed ID: 6846084
[TBL] [Abstract][Full Text] [Related]
2. Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension.
Van Aken H; Puchstein C; Schweppe ML; Heinecke A
Acta Anaesthesiol Scand; 1982 Dec; 26(6):615-9. PubMed ID: 7158271
[TBL] [Abstract][Full Text] [Related]
3. The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension.
Van Aken H; Puchstein C; Anger C; Lawin P
Intensive Care Med; 1983; 9(3):123-6. PubMed ID: 6863721
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage.
Qureshi AI; Wilson DA; Hanley DF; Traystman RJ
Crit Care Med; 1999 May; 27(5):965-71. PubMed ID: 10362421
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
[TBL] [Abstract][Full Text] [Related]
6. The use of labetalol in producing deliberate hypotension and its effects on intracranial pressure in dogs.
Van Aken H; Puchstein C; Hidding J
Acta Anaesthesiol Belg; 1982; 33(1):5-12. PubMed ID: 7090725
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
8. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
Koch G
Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
[No Abstract] [Full Text] [Related]
9. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
Lüben V; Rieder W; Zierski J; Hempelmann G
Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
[TBL] [Abstract][Full Text] [Related]
10. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
Vas A; Gachályi B; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
[No Abstract] [Full Text] [Related]
11. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of long-term oral labetalol.
Edwards RC; Raftery EB
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in the elderly with labetalol.
Sirgo MA; Boyd BK; Applegate WB
Pharmacotherapy; 1989; 9(5):295-302. PubMed ID: 2682551
[TBL] [Abstract][Full Text] [Related]
15. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
17. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
[TBL] [Abstract][Full Text] [Related]
18. [The effect of combined alpha and beta blockade with labetalol on the haemodynamics of stress reaction in hypertensives (author's transl)].
Bahlmann J; Brod J; Hubrich W; Pretschner P
Dtsch Med Wochenschr; 1980 Oct; 105(41):1414-8. PubMed ID: 7449643
[TBL] [Abstract][Full Text] [Related]
19. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
20. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
